- Home
- FF vs ABEO Comparison
FF vs ABEO Comparison
Compare FF & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FF
- ABEO
- Stock Information
- Founded
- FF N/A
- ABEO N/A
- Country
- FF United States
- ABEO United States
- Employees
- FF N/A
- ABEO N/A
- Industry
- FF Major Chemicals
- ABEO Biotechnology: Pharmaceutical Preparations
- Sector
- FF Industrials
- ABEO Health Care
- Exchange
- FF Nasdaq
- ABEO Nasdaq
- Market Cap
- FF 270.9M
- ABEO 277.6M
- IPO Year
- FF N/A
- ABEO 1980
- Fundamental
- Price
- FF $6.05
- ABEO $6.54
- Analyst Decision
- FF Strong Buy
- ABEO Strong Buy
- Analyst Count
- FF 1
- ABEO 3
- Target Price
- FF $0.80
- ABEO $18.00
- AVG Volume (30 Days)
- FF 266.5K
- ABEO 287.8K
- Earning Date
- FF 11-08-2024
- ABEO 11-11-2024
- Dividend Yield
- FF 3.92%
- ABEO N/A
- EPS Growth
- FF N/A
- ABEO N/A
- EPS
- FF 0.91
- ABEO N/A
- Revenue
- FF $339,451,000.00
- ABEO N/A
- Revenue This Year
- FF N/A
- ABEO N/A
- Revenue Next Year
- FF N/A
- ABEO $7,097.06
- P/E Ratio
- FF $6.78
- ABEO N/A
- Revenue Growth
- FF N/A
- ABEO 147.52
- 52 Week Low
- FF $4.15
- ABEO $3.05
- 52 Week High
- FF $8.36
- ABEO $9.01
- Technical
- Relative Strength Index (RSI)
- FF 55.48
- ABEO 62.48
- Support Level
- FF $5.82
- ABEO $6.39
- Resistance Level
- FF $6.36
- ABEO $6.74
- Average True Range (ATR)
- FF 0.18
- ABEO 0.31
- MACD
- FF 0.04
- ABEO -0.01
- Stochastic Oscillator
- FF 59.21
- ABEO 79.59
About FF FutureFuel Corp. Common shares
FutureFuel Corp makes and sells diversified chemical products, bio-based fuel products, and specialty chemical products. The company is organized into two segments based on product type: biofuels and chemicals. The biofuel segment sells biodiesel and other petroleum products. Its fuels are made from a mix of diesel, vegetable oils, and grease feedstock. The chemicals segment sells products that are used in the production of agricultural chemicals, which include herbicides, coatings, and cleaning products, such as detergents.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.